VP
ABBV icon

Verum Partners’s AbbVie ABBV Stock Holding History

Verum Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$969K Buy
3,851
+428
+13% +$92.1K 0.14% 81
2026
Q1 		$744K Buy
3,423
+164
+5% +$36.4K 0.14% 87
2025
Q4 		$745K Sell
3,259
-156
-5% -$35.5K 0.15% 75
2025
Q3 		$791K Sell
3,415
-50
-1% -$10.2K 0.17% 72
2025
Q2 		$643K Buy
3,465
+670
+24% +$125K 0.15% 79
2025
Q1 		$586K Sell
2,795
-89
-3% -$17.3K 0.16% 72
2024
Q4 		$513K Sell
2,884
-82
-3% -$15.1K 0.15% 87
2024
Q3 		$586K Buy
2,966
+185
+7% +$34.5K 0.17% 77
2024
Q2 		$477K Sell
2,781
-2
-0.1% -$331 0.15% 82
2024
Q1 		$507K Sell
2,783
-115
-4% -$19.8K 0.18% 83
2023
Q4 		$449K Sell
2,898
-33
-1% -$4.81K 0.18% 83
2023
Q3 		$437K Buy
2,931
+1,017
+53% +$149K 0.2% 80
2023
Q2 		$258K Buy
+1,914
New +$281K 0.23% 74

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Verum Partners's ABBV Position: Q2 2026 in Review

Verum Partners increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $92.1K and bringing the position to 3,851 shares worth $969K. The position accounts for 0.14% of the portfolio, ranked #81.

Verum Partners first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 1,171 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Verum Partners held 3,851 shares of AbbVie worth $969K as of Q2 2026.
  • Verum Partners bought 428 AbbVie shares in Q2 2026, an estimated $92.1K.
  • AbbVie made up 0.14% of Verum Partners's portfolio in Q2 2026, its #81 holding.
  • Verum Partners first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
  • 1,171 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.